China vaccine scandal ripples through domestic market, threatens global push Ruby Khatun Khatun24 July 2018 9:45 AM ISTSHANGHAI: A vaccine scandal in China, which has hit a nerve in the country and prompted quick reactions from leaders in Beijing, is sending ripples...
Over 75 percent of Indian drug import comes from China says pharma body IPCA Ruby Khatun Khatun21 Dec 2017 9:30 AM ISTNew Delhi: An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the...
China accounts for 66 percent of India's bulk drug imports in FY'17 Ruby Khatun Khatun20 Dec 2017 10:15 AM ISTNew Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
AstraZeneca steps up China push with new drug joint venture Ruby Khatun Khatun28 Nov 2017 1:50 PM ISTLONDON: Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a...
Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar Ruby Khatun Khatun5 Oct 2017 10:53 AM ISTNew Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 percent in Hyderabad-based Gland Pharma at a valuation of not more than USD...
OrbiMed lines up 551 million dollar healthcare PE fund for China, India Ruby Khatun Khatun9 Sept 2017 10:17 AM ISTNEW YORK: OrbiMed, a leading investment firm focused on the healthcare sector, announced the closing of its third Asia-focused private equity fund,...
